Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
2015
Background
The outcomes of infliximab dose escalation in ulcerative colitis (UC) have not been well evaluated.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
31
References
20
Citations
NaN
KQI